Abstract |
Gene expression signatures for a basal-like breast cancer (BLBC) subtype have been associated with poor clinical outcomes, but a molecular basis for this disease remains unclear. Here, we report overexpression of the transcription factor FOXC1 as a consistent feature of BLBC compared with other molecular subtypes of breast cancer. Elevated FOXC1 expression predicted poor overall survival in BLBC (P = 0.0001), independently of other clinicopathologic prognostic factors including lymph node status, along with a higher incidence of brain metastasis (P = 0.02) and a shorter brain metastasis-free survival in lymph node-negative patients (P < 0.0001). Ectopic overexpression of FOXC1 in breast cancer cells increased cell proliferation, migration, and invasion, whereas shRNA-mediated FOXC1 knockdown yielded opposite effects. Our findings identify FOXC1 as a theranostic biomarker that is specific for BLBC, offering not only a potential prognostic candidate but also a potential molecular therapeutic target in this breast cancer subtype.
|
Authors | Partha S Ray, Jinhua Wang, Ying Qu, Myung-Shin Sim, Jaime Shamonki, Sanjay P Bagaria, Xing Ye, Bingya Liu, David Elashoff, Dave S Hoon, Michael A Walter, John W Martens, Andrea L Richardson, Armando E Giuliano, Xiaojiang Cui |
Journal | Cancer research
(Cancer Res)
Vol. 70
Issue 10
Pg. 3870-6
(May 15 2010)
ISSN: 1538-7445 [Electronic] United States |
PMID | 20406990
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | (c)2010 AACR. |
Chemical References |
- Biomarkers, Tumor
- FOXC1 protein, human
- Forkhead Transcription Factors
- RNA, Messenger
- RNA, Small Interfering
|
Topics |
- Apoptosis
- Biomarkers, Tumor
(genetics, metabolism)
- Blotting, Western
- Bone Neoplasms
(genetics, metabolism, secondary)
- Breast
(metabolism, pathology)
- Breast Neoplasms
(genetics, metabolism, pathology)
- Carcinoma, Basal Cell
(genetics, metabolism, pathology)
- Cell Adhesion
- Cell Movement
- Cell Proliferation
- Cells, Cultured
- Female
- Forkhead Transcription Factors
(antagonists & inhibitors, genetics, metabolism)
- Gene Expression Profiling
- Humans
- Oligonucleotide Array Sequence Analysis
- Prognosis
- RNA, Messenger
(genetics, metabolism)
- RNA, Small Interfering
(pharmacology)
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
|